ELICIO THERAPEUTICS, INC.

Profile

Company Names

ELICIO THERAPEUTICS, INC.
VEDANTRA PHARMACEUTICALS, INC.

Addresses

451 D STREET, 5TH FLOOR, SUITE 501, BOSTON, MA 02210

ONE KENDALL SQUARE, BUILDING 1400 WEST, SUITE 14303, CAMBRIDGE, MA 02139

ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142

Phone Numbers

857-209-0050
617-360-9995

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$105,312,570.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2022-05-12 
$21,995,420.00 
$50,000,000.00 
$28,004,580.00 
Equity 
9
2021-10-04 
$14,470,000.00 
$15,000,000.00 
$530,000.00 
Debt 
8
2020-06-30 
$6,085,000.00 
$30,000,000.00 
$23,915,000.00 
Equity 
7
2020-02-27 
$8,411,801.00 
$8,411,801.00 
$0.00 
Equity 
6
2019-09-30 
$7,000,000.00 
$7,000,000.00 
$0.00 
Equity 
5
2018-08-30 
$25,817,848.00 
$36,235,347.00 
$10,417,499.00 
Equity 
4
2018-07-20 
$14,492,501.00 
$14,492,501.00 
$0.00 
Debt 
3
2018-05-21 
$2,990,000.00 
$3,000,000.00 
$10,000.00 
Debt 
2
2016-05-16 
$750,000.00 
$1,500,000.00 
$750,000.00 
Equity, Debt 
1
2012-07-18 
$3,300,000.00 
$5,000,000.00 
$1,700,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JULIAN 
 
ADAMS 
DIRECTOR, EXECUTIVE OFFICER
CAROL 
 
ASHE 
DIRECTOR
YEKATERINA 
 
CHUDNOVSKY 
DIRECTOR
ROBERT 
 
CONNELLY 
EXECUTIVE OFFICER, DIRECTOR
STEVE 
 
DEITCHER 
DIRECTOR
OFER 
 
GONEN 
DIRECTOR
FRANK 
 
HALUSKA 
DIRECTOR
SATISH 
 
JINDAL 
DIRECTOR
DAPHNE 
 
KARYDAS 
DIRECTOR
ANNETTE 
 
MATTHIES 
EXECUTIVE OFFICER
ASSAF 
 
SEGAL 
DIRECTOR
ALAN 
 
SHAW 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-05-12 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-05-12 
D/A
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-10-04 
D/A
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-10-04 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-10-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-27 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-07-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-05-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-05-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
FINALIS SECURITIES LLC
FINALIS SECURITIES LLC
LEOPOLDO WALTER
MAXIM MERCHANT CAPITAL
NONE
NONE